Table 2 Cox proportional hazard models

From: Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

 

Single-variate analyses

Multivariate analysis

Variable

Crude HR

95% CI

P value

AHR

95% CI

P value

FokI C/C: 66

0.26

0.09–0.76

0.014

0.18

0.05–0.61

0.006

FokI C/T or T/T: 35

Reference

  

Reference

  

Stage I: 41

0.05

0.005–0.42

0.006

0.02

0.002–0.28

0.004

Stage II: 6

0.78

0.14–4.32

0.78

0.76

0.89–6.54

0.81

Stage III: 44

1.32

0.45–3.86

0.62

1.09

0.33–3.61

0.89

Stage IV: 10

Reference

  

Reference

  

Histology

 Endometrioid: 21

0.17

0.02–1.71

0.13

0.05

0.03–0.95

0.04

 Clear Cell: 35

0.51

0.06–4.04

0.52

0.53

0.05–5.16

0.58

 Serous: 38

0.60

0.08–4.70

0.63

0.08

0.07–0.88

0.04

 Mucinous: 6

Reference

  

Reference

  

 Mixed mesodermal: 1

0.27

0.02–4.31

0.35

0.09

0.04–2.10

0.13

Residual tumour

 None: 69

Reference

  

Reference

  

 <2 cm: 12

5.67

1.84–17.43

0.003

1.73

0.39–7.69

0.47

 ⩾2 cm: 20

11.19

4.36–28.72

<0.001

4.93

1.31–18.53

0.02

 Age

1.06

1.01–1.10

0.005

1.01

0.98–1.05

0.49

  1. Abbreviations: HR=hazard ratio; CI=confidence interval; AHR=adjusted hazard ratio.
  2. Adjusted for postoperative stages, postoperative chemotherapy, histology (endometrioid, clear cell, serous, mucinous, mixed mesodermal), and residual tumour (none, <2 cm, ⩾2 cm).
Back to article page